Correction to: Bone Marrow Transplantationhttps://doi.org/10.1038/s41409-023-02174-2 published online 06 January 2024 In this article, the author name Elisabeth Dagunet is incorrectly given. It should read Elisabeth Daguenet. Also, the affiliation 3 EBMT Paris study office; Department of Haematology, Saint Antoine Hospital; INSERM UMR-S 938, Sorbonne University, Paris, France is given incorrectly. It should be CHU de Saint-Etienne, Hematology, Saint-Etienne. France. The original article has been corrected.

Penack, O., Peczynski, C., Boreland, W., Lemaitre, J., Reinhardt, H. C., Afanasyeva, K., Avenoso, D., Holderried, T. A. W., Kornblit, B. T., Gavriilaki, E., Martinez, C., Chiusolo, P., Mico, M. C., Daguenet, E., Wichert, S., Ozdogu, H., Piekarska, A., Kinsella, F., Basak, G. W., Schoemans, H., Koenecke, C., Moiseev, I., Peric, Z., Correction to: ECP versus ruxolitinib in steroid-refractory chronic GVHD – a retrospective study by the EBMT transplant complications working party (Bone Marrow Transplantation, (2024), 59, 3, (380-386), 10.1038/s41409-023-02174-2), <<BONE MARROW TRANSPLANTATION>>, 2024; 60 (1): 380-386. [doi:10.1038/s41409-024-02435-8] [https://hdl.handle.net/10807/311955]

Correction to: ECP versus ruxolitinib in steroid-refractory chronic GVHD – a retrospective study by the EBMT transplant complications working party (Bone Marrow Transplantation, (2024), 59, 3, (380-386), 10.1038/s41409-023-02174-2)

Chiusolo, Patrizia;
2025

Abstract

Correction to: Bone Marrow Transplantationhttps://doi.org/10.1038/s41409-023-02174-2 published online 06 January 2024 In this article, the author name Elisabeth Dagunet is incorrectly given. It should read Elisabeth Daguenet. Also, the affiliation 3 EBMT Paris study office; Department of Haematology, Saint Antoine Hospital; INSERM UMR-S 938, Sorbonne University, Paris, France is given incorrectly. It should be CHU de Saint-Etienne, Hematology, Saint-Etienne. France. The original article has been corrected.
2025
Inglese
Penack, O., Peczynski, C., Boreland, W., Lemaitre, J., Reinhardt, H. C., Afanasyeva, K., Avenoso, D., Holderried, T. A. W., Kornblit, B. T., Gavriilaki, E., Martinez, C., Chiusolo, P., Mico, M. C., Daguenet, E., Wichert, S., Ozdogu, H., Piekarska, A., Kinsella, F., Basak, G. W., Schoemans, H., Koenecke, C., Moiseev, I., Peric, Z., Correction to: ECP versus ruxolitinib in steroid-refractory chronic GVHD – a retrospective study by the EBMT transplant complications working party (Bone Marrow Transplantation, (2024), 59, 3, (380-386), 10.1038/s41409-023-02174-2), <<BONE MARROW TRANSPLANTATION>>, 2024; 60 (1): 380-386. [doi:10.1038/s41409-024-02435-8] [https://hdl.handle.net/10807/311955]
File in questo prodotto:
File Dimensione Formato  
unpaywall-bitstream-543715801.pdf

accesso aperto

Tipologia file ?: Versione Editoriale (PDF)
Licenza: Creative commons
Dimensione 601.35 kB
Formato Adobe PDF
601.35 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10807/311955
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 0
  • ???jsp.display-item.citation.isi??? ND
social impact